FDA
-
-
-
-
-
-
-
Therapix Biosciences (TRPX) Reports Positive Data From Pre-clinical Studies for THX-160 for Treatment of Pain
-
-
-
-
-
-
-
Therapix to Present at and Attend Investor Conferences in London
-
-
-
-
-
-
-
Therapix Biosciences Ltd. Announces Full Exercise of Underwriters' Over-Allotment Option
-
-
-
325,295 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

